Elderberry Trial 

Improving immune support.

Canva Design DAE--pg1p_g

Who can join?

You can join this study if you are an otherwise healthy, male or female aged 20 - 65. This study is available to those that live in the United States. 

Canva Design DAE--pg1p_g

What's involved?

This study involves taking 1 elderberry capsules twice a day for 90 days. There will also be daily surveys monitoring your general health throughout the 90 days.

 

 

 

Canva Design DAE--pg1p_g

Will I be paid?

Yes! Our team compensates for your time taking the elderberry supplements and taking the daily surveys. You will receive up to $70 if you finish the trial.

 

What are the steps?

Getting Started

To join the study, complete the form below. Our research team will send you an email with a survey for our team to learn more about your health status. If our team decides this study is a good fit, you will be reached out to schedule receiving your supply of capsules, as well as a start date. Our team will be available to make sure all your questions are answered. 

 

One

During the Study

While you are in the study, you will take 1 elderberry capsule twice a day for 90 days. You will also complete a symptom checklist for any day during this time that you experience symptoms of illness.

After the study ends, we'll invite you to a webinar so you can learn more about what our study found. 

Two

Payment & Support

Our team is available to you 24/7 during the study. You can reach out at any time with questions. 

You will be compensated for all portions of the study completed (up to $120), within approximately 2-3 weeks of achieving each benchmark. Payment is sent via an email voucher which can be redeemed for a gift card at one of over 100 popular retailers or a Visa/MC cash card. 

Three

To join this trial, fill out the form below:
Important Info

The purpose of this study is to measure the effects of daily ingestion of an elderberry supplement during the winter virus season. The protocol has been evaluated and approved by an independent ethical review board which is accredited by the US Department of Health and Human Services (HHS) Office of Human Research Protections (OHRP). It is conducted in compliance with the Declaration of Helsinki, the Belmont Report, the regulations outlined in 45 CFR 46, and ICH GCP E6 (R2). The protocol is also registered at a World Health Organization (WHO) approved clinical trial registry.